Enjoy complimentary customisation on priority with our Enterprise License!
The global urinalysis market size is estimated to grow by USD 1,048.77 million at a CAGR of 8.4% between 2023 and 2028.
Urinalysis market Share
For More Highlights About this Report, Download Free Sample in a Minute
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The rising prevalence of renal diseases and UTIs is notably driving the market growth. The prevalence of renal diseases has increased significantly across the world. The geriatric population is more prone to developing CKDs. The incidence of urinary tract infections (UTIs) has increased worldwide. UTIs involve any parts of the urinary system, including the bladder, urethra, and kidney. UTIs more commonly occur among patients during hospitalizations. Catheter-associated UTIs (CAUTIs) are one of the most common hospital-acquired infections (HAIs). Risk factors for developing CAUTI include prolonged catheterization, female gender, older age, and diabetes.
Moreover, urinary screening is majorly used as one of the treatment approaches for the diagnosis of kidney diseases and UTIs among people. Hence, the increasing incidences and prevalence of kidney diseases and UTIs are driving the growth of the global urinalysis market. Therefore, the rising prevalence of renal diseases and UTIs will drive the growth of the global urinalysis market during the forecast period.
The growing need for companion diagnostics is an emerging trend shaping the market growth. A companion diagnostic is mostly an in-vitro POC medical device that provides information that is necessary for the safe and effective use of a similar drug or biological product. Generally, it is administered based on the analysis provided by the diagnostic machine. Companion diagnostics becomes necessary to understand the needs of the patient and provide personalized medicines. This practice has been trending recently and thus becomes a good opportunity to penetrate POC products into new markets.
However, the primary advantages of POC urinalysis devices are rapid turnaround time for test results and increased mobility, which significantly improve the quality of care and clinical outcomes. This can result in improved disease management, treatment adherence, and patient satisfaction. Therefore, the growing need for companion diagnostics will drive the growth of the global urinalysis market during the forecast period.
Increasing growth potential for urinalysis market in emerging economies is a significant challenge hindering market growth. The healthcare industry, including hospitals and clinics in developing economies, is growing at a tremendous pace, owing to the ongoing demographic shifts and rising healthcare expenditure. The growth in the number of large and mid-sized hospitals in emerging economies is also propelling the demand for advanced screening and diagnostic procedures. For instance, in an article published by Institut Montaigne in 2020, the total number of private and public hospitals in India was 43,486 and 25,778, respectively.
Similarly, the total number of hospitals in China until 2020 was around 25,400. The number of private and public hospitals in developing countries is expected to increase in the coming years owing to the increasing needs of the population for the diagnosis and treatment of various medical conditions, which, in turn, is expected to boost the demand for various medical instruments, including the devices and consumables required for urinalysis. This, in turn, is expected to increase the opportunity for the global urinalysis market during the forecast period.
The product segment is classified into consumables and instruments. The end-user segment is classified into hospital and clinics, diagnostic laboratories, and home care settings. The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW).
The market share growth by the consumables segment will be significant during the forecast period. Consumables were the largest segment of the global urinalysis market in 2023 and are expected to continue to be the largest segment of the market during the forecast period. Factors such as an increase in the demand for advanced urinary consumables, improved accuracy, and convenience of urinalysis testing lead to an increase in demand for urinalysis consumables.
Get a glance at the market contribution of various segments Download the PDF Sample
The consumables segment was the largest and was valued at USD 1,197.10 million in 2018. The advanced urinary consumables are easy to use and convenient to handle and can be stored for a longer duration and retain the same quality. The independent quality control in the advanced consumables monitors the precision of laboratory urinalysis test procedures, improves efficiency, and reduces the risk of error. The increase in demand for advanced urinary consumables will propel the growth of the segment in the global urinalysis market during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The increasing prevalence of renal diseases, growing number of hospitalizations associated with UTIs, rising awareness about the screening of urine samples, increasing adoption of technologically advanced products for urinalysis, rising healthcare spending, and the presence of prominent vendors are the major factors driving the growth of the global urinalysis market in North America. Screening and diagnosis are required for the early detection of kidney diseases. The prevalence of kidney diseases in North America has increased significantly. Kidney diseases are one of the major causes of the increasing mortality rate in the US. This is driving the growth of the global urinalysis market in North America during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
77 Elektronika Kft - The company offers urinalysis treatment through LabStrip U11 Plus and LabStrip U11 Plus GL high-grade, multiparameter urinalysis test strips.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
|
Urinalysis Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
164 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 8.4% |
|
Market growth 2024-2028 |
USD 1,048.77 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
7.18 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 37% |
|
Key countries |
US, Germany, UK, China, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
77 Elektronika Kft, Abbott Laboratories, ACON Laboratories Inc., AdvaCare Pharma, ARKRAY Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BIOGENIX Inc. Pvt. Ltd., bioMerieux SA, Cardinal Health Inc., Danaher Corp., Dirui Industrial Co. Ltd., F. Hoffmann La Roche Ltd., Medline Industries LP, Mindray Bio medical Electronics Co. Ltd., Quidelortho Corp., Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and URIT Medical Electronic Co. Ltd. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Get the report (PDF) sent to your email within minutes.
